Analyst Ratings for Rhythm Pharmaceuticals (RYTM)
RYTM Rating Summary
RYTM Price Target Summary
- Highest: $70.00 (Canaccord Genuity)
- Lowest: $49.00 (BofA Securities)
- Average: $54.13
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$54.13 (+41.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$54.13 (+41.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/19/2023 | Morgan Stanley | Jeffrey Hung | Upgrade | Overweight (Equalweight) |
55.00 (29.00) |
47.20 (38.15) |
-19.17% | Details |
| 8/1/2023 | BofA Securities » Updated 1/12/2024 |
Tazeen Ahmad | Upgrade | Buy (Neutral) |
49.00 (31.00) |
17.84 (38.15) |
113.85% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
